Literature DB >> 15195014

Radiological contrast studies after vertical banded gastroplasty (VBG) and Roux-en-Y gastric bypass (RYGBP) in patients with morbid obesity. Study of the complications.

Francesco Mondeturo1, Ivanpietro Cappello, Gianni Mazzoni, Libero Barozzi, Antonella Ghetti, Daniela Nottola, Stefano Cariani, Enrico Amenta.   

Abstract

PURPOSE: The aim of the study was to evaluate the role of radiological upper gastroenteric studies to detect early and postoperative complications after gastric restrictive surgery for obesity.
MATERIALS AND METHODS: From October 1992 to October 2002, 650 patients submitted to vertical banded gastroplasty (VBG) and Roux-en-Y gastric bypass (RYGBP) underwent radiological follow-up to assess the presence of both early and late postoperative complications. The patients were 546 (84%) women and 104 (16%) men whose average weight was 125 kg (range: 78 to 218 kg). The average female age was 37 years (range: 17 to 69 years) and the average male age 36 (range: 19 to 64 years). Preoperative mean body mass index was 46 kg/m2 (range 31-78 kg/m2). The patients underwent radiological upper gastroenteric investigation employing water soluble contrast material between the 4th and 7th postoperative day. All patients underwent another late examination every year after surgery.
RESULTS: At 10 years follow-up in 620 patients submitted to modified Mason VBG we observed the following early postoperative complications: 16 cases (2.6%) of oedema of the stoma, six cases (0.9%) of gastro-oesophageal reflux, one case (0.2%) of staple-line disruption, and one case (0.2%) of intragastric haemorrhage. Late complications in VBG included 26 cases (4.2%) of staple-line disruption, four cases (0.6%) of kinked stomas, six cases (0.9%) of pouch dilatations, two cases (0.4%) of stomal stenosis and one case (0.2%) of gastro-oesophageal reflux. In 30 RYGBP patients we observed the following early postoperative complications: one case (0.8%) of dilated pouch, one case (0.8%) of oedema of the anastomosis and one case (0.8%) of anastomotic leak. Late postoperative complications in the 30 RYGBP patients included three cases (2.5%) of stomal ulcers and one case (0.8%) of gastro-oesophageal reflux. We also examined the annual incidence of complications in late follow-up. DISCUSSION AND
CONCLUSIONS: Both early and late radiological studies after gastric bariatric surgery enable the detection of postoperative complications and provided morphological and volumetric data after VBG and RYGBP. Post-operative complications (gastric perforation, stomal stenosis, etc.) need to be emphasised and the clinical approach modified to enable suitable weight loss.

Entities:  

Mesh:

Year:  2004        PMID: 15195014

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  5 in total

1.  SAGES guideline for clinical application of laparoscopic bariatric surgery.

Authors: 
Journal:  Surg Endosc       Date:  2008-10       Impact factor: 4.584

2.  Natural orifice surgery: endoluminal pouch reduction following failed vertical banded gastroplasty.

Authors:  Namdar Manouchehri; Daniel W Birch; Carlos Menzes; Xinzhe Shi; Shahzeer Karmali
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

3.  Metastatic adenocarcinoma of the gastric pouch 5 years after Roux-en-Y gastric bypass.

Authors:  Christine Sun; Christian S Jackson; Mark Reeves; Stewart Rendon
Journal:  Obes Surg       Date:  2008-01-25       Impact factor: 4.129

Review 4.  Clinical application of laparoscopic bariatric surgery: an evidence-based review.

Authors:  Timothy M Farrell; Stephen P Haggerty; D Wayne Overby; Geoffrey P Kohn; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2009-01-06       Impact factor: 4.584

5.  Abnormal findings on routine upper GI series following laparoscopic Roux-en-Y gastric bypass.

Authors:  Raghav Raman; Bhargav Raman; Pavithra Raman; Stanford Rossiter; Myriam J Curet; Robert Mindelzun; John M Morton
Journal:  Obes Surg       Date:  2007-03       Impact factor: 3.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.